Want to see PBLS full AI Analyst Report?

Parabilis Medicines, Inc. (PBLS) Financial Statements

29 Followers

Parabilis Medicines, Inc. Financial Overview

Parabilis Medicines, Inc.'s market cap is currently $4.75B. The company's EPS TTM is $; its P/E ratio is -1.04; Parabilis Medicines, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24
Income Statement
Total Revenue	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00
Operating Income	$ -152.08M	$ -126.13M
EBITDA	$ -141.87M	$ -114.33M
Net Income	$ -145.89M	$ -117.91M
Balance Sheet
Cash & Short-Term Investments	$ 27.71M	$ 87.98M
Total Assets	$ 80.82M	$ 149.25M
Total Debt	$ 58.70M	$ 66.20M
Net Debt	$ 30.99M	$ 18.91M
Total Liabilities	$ 97.34M	$ 92.81M
Stockholders' Equity	$ -16.52M	$ 56.44M
Cash Flow
Free Cash Flow	$ -124.02M	$ -104.49M
Operating Cash Flow	$ -123.71M	$ -103.61M
Investing Cash Flow	$ 39.76M	$ 30.24M
Financing Cash Flow	$ 64.38M	$ 78.08M

Currency in USD

Parabilis Medicines, Inc. Earnings and Revenue History

Income Statement >

Parabilis Medicines, Inc. Debt to Assets

Balance Sheet >

Parabilis Medicines, Inc. Cash Flow

Cash Flow >

Parabilis Medicines, Inc. Forecast EPS vs Actual EPS

Earnings >